Clinical Trial

Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults

Unknown Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and safety of Fecal Microbiota Transplantation compared with placebo in the treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) and Mental Health Comorbidity in Young Adults.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06297421
Lead Sponsor Shenzhen Hospital of Southern Medical University
Conditions Irritable Bowel Syndrome With Diarrhea, Fecal Microbiota Transplantation, Mental Health Issue
Enrollment 88 participants
Start Date 2024-09
Primary Completion 2026-01 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2024-07-16